One label, very different records
“Research peptide” is a market description rather than a single scientific class. BPC-157, fragments associated with thymosin beta-4 and copper-binding GHK-Cu have different proposed mechanisms, study histories and routes of use. They should not inherit evidence from one another.
Separate evidence levels
Cell and animal experiments can justify further research but do not establish a clinical effect in people. Human observational work, controlled trials and authorised indications answer different questions, so LabCheck records them separately instead of combining them into one evidence score.
COAs answer product questions
A laboratory report may address identity or measured purity for a submitted sample. It does not establish clinical effectiveness, sterility, stability after shipping or consistency across every unit sold under the same batch label unless those questions were actually tested.